What does CUSIP 918640301 represent in this 13F holders report?

CUSIP 918640301 is the security identifier for VCNX - VACCINEX, INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held VCNX - VACCINEX, INC. - Common Stock, par value $0.0001 per share in Q3 2025?

1 institutional investor reported VCNX - VACCINEX, INC. - Common Stock, par value $0.0001 per share for Q3 2025. Use the holders table for investor-level position and value details.

VACCINEX, INC. - Common Stock, par value $0.0001 per share (VCNX)

CUSIP: 918640301

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 27
Total 13F value: $92
Share change: +27
SEC-reported price per share: $3.41
Number of holders: 1
Value change: +$92
Number of buys: 1
Shares outstanding: 2,736,253

Security key

918640301

Report period

Q3 2025

Institutions

Top holders

VCNX full security history Ownership snapshot Newer quarter: Q4 2025 VACCINEX, INC. SEC filings VACCINEX, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 918640301

Newer quarter: Q4 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of VCNX - VACCINEX, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

Albert Friedberg

Comparable rows

1/14

Latest evidence

31 Dec 2024

13D/G 3/4/5 Lead comparable stake: 5% 13 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 14 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

1 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 1

ARMISTICE CAPITAL, LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 14 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13D/G 13D/G	5% Reported 13D/G · 31 Dec 2024	$103,770 136,539 shares	$0	31 Dec 2024
Albert Friedberg	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	$5,378,799 1,655,033 shares mixed-class rows	—	14 Nov 2024
Maurice Zauderer	3/4/5 President and CEO, Director, 10%+ Owner 3/4/5	— mixed-class rows	$1,008,773 473,900 shares mixed-class rows	—	14 Nov 2024
Jacob B. Frieberg	3/4/5 Director 3/4/5	— mixed-class rows	$47,946 11,782 shares mixed-class rows	—	10 May 2024
Gerald E. van Strydonck	3/4/5 Director 3/4/5	— mixed-class rows	$43,150 10,651 shares mixed-class rows	—	10 May 2024
Bala S. Manian	3/4/5 Director 3/4/5	— denominator unverified	$40,028 10,108 shares	—	10 May 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

VCNX full security history Newer quarter: Q4 2025